Cargando…
Breast cancer cell lines: friend or foe?
The majority of breast cancer research is conducted using established breast cancer cell lines as in vitro models. An alternative is to use cultures established from primary breast tumours. Here, we discuss the pros and cons of using both of these models in translational breast cancer research.
Autores principales: | Burdall, Sarah E, Hanby, Andrew M, Lansdown, Mark RJ, Speirs, Valerie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154155/ https://www.ncbi.nlm.nih.gov/pubmed/12631387 |
Ejemplares similares
-
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
T Cells in Gastric Cancer: Friends or Foes
por: Amedei, Amedeo, et al.
Publicado: (2012) -
Anthracyclines in the treatment of early breast cancer friend or foe?
por: Vuger, Ana Tecic, et al.
Publicado: (2022) -
Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019) -
Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)